Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils

Citation
C. Hess et al., Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils, BLOOD, 96(8), 2000, pp. 2722-2727
Citations number
44
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
96
Issue
8
Year of publication
2000
Pages
2722 - 2727
Database
ISI
SICI code
0006-4971(20001015)96:8<2722:IONRTM>2.0.ZU;2-8
Abstract
Antibodies against myeloperoxidase (MPO) and proteinase 3 (PR3) are the pre dominant autoantibodies present in antineutrophil cytoplasmic antibody (ANC A)-associated vasculitis, Their binding to the corresponding antigen on the surface of polymorphonuclear neutrophils (PMNs) is believed to trigger the disease process. Cytokines released during an inflammatory reaction are th ought to prime resting PMNs, making them responsive to autoantibodies. In t he present study we found that MPO but not PR3 could be detected on the cel l surface of unstimulated PMNs after incubation with the supernatants of ac tivated autologous PMNs. MPO was shown to be acquired from these supernatan ts, because PMNs did not express MPO when the supernatants were specificall y MPO-depleted. In addition, purified soluble MPO bound to unstimulated PMN s, Unstimulated PMNs that had passively acquired MPO released oxygen radica ls when incubated with monoclonal antibody anti-MPO or the immunoglobulin G fraction of a patient with MPO-ANCA. The data presented here suggest that, in ANCA-associated vasculitis, soluble MPO released by activated PMNs may bind to unstimulated PMNs, thereby making them reactive to anti-MPO antibod ies. This mechanism of dispersing PMN activation would be specific for MPO- ANCA and may explain differences in the pathologic and clinical expression of MPO-ANCA versus PR3-ANCA vasculitis, (Blood, 2000;96:2822-2827) (C) 2000 by The American Society of Hematology.